Cargando…

Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation

Hepatic gluconeogenesis plays an important role in maintaining the body’s glucose metabolism homeostasis. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver diseases, when combined with type 2 diabetes mellitus (T2DM), it can cause severe glucose metabolism disorders...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongxue, Xu, Qian, Xu, Chengye, Hu, Yuxin, Yu, Xingyang, Zhao, Kangqi, Li, Mingqing, Li, Meng, Xu, Junfang, Kuang, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175979/ https://www.ncbi.nlm.nih.gov/pubmed/34093184 http://dx.doi.org/10.3389/fphar.2021.644129

Ejemplares similares

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Wu, Jingyi, et al.
Publicado: (2023)

Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Frontiers Production Office,
Publicado: (2023)

Bicyclol Attenuates Liver Inflammation Induced by Infection of Hepatitis C Virus via Repressing ROS-Mediated Activation of MAPK/NF-κB Signaling Pathway
por: Li, Hu, et al.
Publicado: (2018)

Dapagliflozin Reduces Apoptosis of Diabetic Retina and Human Retinal Microvascular Endothelial Cells Through ERK1/2/cPLA2/AA/ROS Pathway Independent of Hypoglycemic
por: Hu, Yuxin, et al.
Publicado: (2022)

Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice
por: Zhao, Tian-Ming, et al.
Publicado: (2020)

Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum
por: Yao, Jianzuo, et al.
Publicado: (2022)

Cerebral Gluconeogenesis and Diseases
por: Yip, James, et al.
Publicado: (2017)

Bicyclol Alleviates Signs of BDL-Induced Cholestasis by Regulating Bile Acids and Autophagy-Mediated HMGB1/p62/Nrf2 Pathway
por: Zhao, Jingwen, et al.
Publicado: (2021)

Proteomics identifies new potential therapeutic targets of diabetic retinopathy
por: Zhou, Huanran, et al.
Publicado: (2022)

Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3
por: Xie, Wei, et al.
Publicado: (2018)

Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication
por: Huang, Meng-Hao, et al.
Publicado: (2019)

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
por: Li, Yunjia, et al.
Publicado: (2022)

Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis
por: Winkler, Robin, et al.
Publicado: (2012)

Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience
por: Chi, Xiaoling, et al.
Publicado: (2019)

Cannabis sativa L. (var. indica) Exhibits Hepatoprotective Effects by Modulating Hepatic Lipid Profile and Mitigating Gluconeogenesis and Cholinergic Dysfunction in Oxidative Hepatic Injury
por: Erukainure, Ochuko L., et al.
Publicado: (2021)

Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes
por: Ji, Xueying, et al.
Publicado: (2019)

Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats
por: Liu, Xin, et al.
Publicado: (2017)

A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury
por: Naqiong, Wu, et al.
Publicado: (2017)

Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis
por: Li, Hu, et al.
Publicado: (2020)

Effect of Bicyclol Tablets on Drug Induced Liver Injuries after Kidney Transplantation
por: Shang, Wenjun, et al.
Publicado: (2017)

Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
por: Mu, Wan, et al.
Publicado: (2019)

Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes
por: Meng, Ziyu, et al.
Publicado: (2023)

Sam68 promotes hepatic gluconeogenesis via CRTC2
por: Qiao, Aijun, et al.
Publicado: (2021)

Unraveling the Regulation of Hepatic Gluconeogenesis
por: Zhang, Xueping, et al.
Publicado: (2019)

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
por: Wang, Man, et al.
Publicado: (2022)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease
por: Zhu, Shenghu, et al.
Publicado: (2020)

Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice
por: Xu, Jia, et al.
Publicado: (2022)

Aqueous Extract of Black Maca Prevents Metabolism Disorder via Regulating the Glycolysis/Gluconeogenesis-TCA Cycle and PPARα Signaling Activation in Golden Hamsters Fed a High-Fat, High-Fructose Diet
por: Wan, Wenting, et al.
Publicado: (2018)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
por: Xu, Yu, et al.
Publicado: (2020)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice
por: Li, Xi, et al.
Publicado: (2018)

Control of hepatic gluconeogenesis by Argonaute2
por: Yan, Xin, et al.
Publicado: (2018)

PIMT regulates hepatic gluconeogenesis in mice
por: Kapadia, Bandish, et al.
Publicado: (2023)

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
por: Zheng, Yiyuan, et al.
Publicado: (2022)

1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea Protects the Blood-Brain Barrier Against Ischemic Injury by Upregulating Tight Junction Protein Expression, Mitigating Apoptosis and Inflammation In Vivo and In Vitro Model
por: Yi, Xingyang, et al.
Publicado: (2020)

Geniposide and Chlorogenic Acid Combination Improves Non-Alcoholic Fatty Liver Disease Involving the Potent Suppression of Elevated Hepatic SCD-1
por: Chen, Cheng, et al.
Publicado: (2021)

The Histone Demethylase Jhdm1a Regulates Hepatic Gluconeogenesis
por: Pan, Dongning, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o7vfrpfgiovho65i62ir0p36k4